School of Medicine
Showing 61-70 of 78 Results
-
Marco Antonio Monroy
Associate Director for Biosciences Graduate Education Initiatives, School of Medicine - Grad Student Support
Current Role at StanfordDirector, Biosciences ADVANCE Institute
Associate Director for Stanford Biosciences Graduate Education Initiatives -
Aurelie Montagne
Affiliate, Department Funds
Fellow in Psychiatry and Behavioral SciencesBioDr. Aurélie Montagne is a psychiatrist whose work centers on psychotherapy, systemic approaches to care, and the organization of psychiatric services. Throughout her training, she has developed advanced expertise across multiple psychotherapy modalities, with a particular interest in group-based interventions. Her research has explored innovative models of care delivery, including teletherapy for complex trauma.
In parallel with her clinical and scholarly work, Dr. Montagne has pursued additional training and supervision in systemic and relational approaches to psychiatry. Her work in this area emphasizes the integration of interpersonal and contextual factors into psychiatric formulation and care.
Dr. Montagne has also been actively engaged in medical education and leadership. She has been a dedicated teacher of medical students and residents and has held leadership roles aimed at strengthening undergraduate psychiatric education. Her clinical expertise extends to day hospital (partial hospitalization) programs, where she integrates psychotherapy, group-based care, and systemic thinking into program development and delivery. She will be joining the McGill University Health Centre as an Assistant Clinical Professor of Psychiatry, where she will lead the Adult Psychiatry Day Hospital. -
Carson T. Moss
Affiliate, Department Funds
BioDr. Carson T. Moss is a Pulmonary and Critical Care Medicine fellow at Stanford University, where he completed his Internal Medicine residency training. His clinical and research program centers on pulmonary complications in immunocompromised patients, with a primary focus on bronchiolitis obliterans syndrome (BOS), a rare and often irreversible obstructive airway disease arising as a manifestation of chronic graft-versus-host disease (cGVHD) following allogeneic hematopoietic cell transplantation (HCT). To characterize disease onset and progression, his investigative work applies quantitative CT imaging and longitudinal pulmonary function metrics as non-invasive diagnostic and monitoring tools, with parallel interest in respiratory infectious complications in this population. Central to this work is an emerging focus on bronchiectasis, particularly as a co-occurring complication of BOS after HCT.
Dr. Moss has contributed to multicenter clinical trials including STOP-BOS, ATHOS-III, and PETAL-ROSE, and his original research has been published in Blood Advances and Transplantation and Cellular Therapy, with findings presented at the American Thoracic Society International Conference. He conducts clinical and translational research within the Hsu Lab, in collaboration with Dr. Joe Hsu. Dr. Moss maintains an active commitment to medical education, with leadership experience in organized medicine and mentorship of trainees across academic medicine.
